The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib. (February 2020)

Record Type:: Journal Article
Title:: The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib. (February 2020)
Main Title:: The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Authors:: Campani, C.
Colagrande, S.
Calistri, L.
Dragoni, G.
Lorini, C.
Castellani, A.
Marra, F.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 52(2020)Supplement 1
Journal:: Digestive and liver disease
Issue:: Volume 52(2020)Supplement 1
Issue Display:: Volume 52, Issue 1 (2020)
Year:: 2020
Volume:: 52
Issue:: 1
Issue Sort Value:: 2020-0052-0001-0000
Page Start:: e51
Page End:: e52
Publication Date:: 2020-02
Subjects:: Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.dld.2019.12.053 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21928.xml